188 related articles for article (PubMed ID: 23235992)
21. Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation.
Lopez-Meseguer M; Berastegui C; Monforte V; Bravo C; Domingo E; Roman A
Transplant Proc; 2013; 45(6):2347-50. PubMed ID: 23953548
[TBL] [Abstract][Full Text] [Related]
22. Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease.
Okumura H; Nagaya N; Kyotani S; Sakamaki F; Nakanishi N; Fukuhara S; Yutani C
Chest; 2002 Sep; 122(3):1096-8. PubMed ID: 12226062
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of epoprostenol therapy in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Ogawa A; Miyaji K; Yamadori I; Shinno Y; Miura A; Kusano KF; Ito H; Date H; Matsubara H
Circ J; 2012; 76(7):1729-36. PubMed ID: 22481098
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary veno-occlusive disease.
Montani D; Price LC; Dorfmuller P; Achouh L; Jaïs X; Yaïci A; Sitbon O; Musset D; Simonneau G; Humbert M
Eur Respir J; 2009 Jan; 33(1):189-200. PubMed ID: 19118230
[TBL] [Abstract][Full Text] [Related]
25. [Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].
Rabanal Llevot JM; Cimadevilla Calvo B; Cifrian Martinez JM; Ruisanchez Villar C; Mons Lera R
Rev Esp Anestesiol Reanim; 2012 Mar; 59(3):142-9. PubMed ID: 22985755
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic pulmonary veno-occlusive disease.
Iwaki M; Imaizumi K; Yokoi T; Kondo M; Kawaguchi K; Hasegawa Y
Intern Med; 2009; 48(15):1289-92. PubMed ID: 19652432
[TBL] [Abstract][Full Text] [Related]
27. [Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis].
Montani D; Dorfmuller P; Maitre S; Jaïs X; Sitbon O; Simonneau G; Humbert M
Presse Med; 2010 Jan; 39(1):134-43. PubMed ID: 19914027
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of idiopathic pulmonary arterial hypertension].
Andreassen AK; Gude E; Solberg OG; Ueland T
Tidsskr Nor Laegeforen; 2011 Jul; 131(13-14):1285-8. PubMed ID: 21725387
[TBL] [Abstract][Full Text] [Related]
29. Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension.
Halank M; Kolditz M; Opitz C; Hoeffken G; Ewert R
Wien Klin Wochenschr; 2006 Feb; 118(1-2):54-9. PubMed ID: 16489527
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary veno-occlusive disease: a case report and a review of therapeutic possibilities.
De Vries TW; Weening JJ; Roorda RJ
Eur Respir J; 1991 Sep; 4(8):1029-32. PubMed ID: 1783079
[TBL] [Abstract][Full Text] [Related]
31. [Pulmonary venous occlusive disease. Case report and literature review].
Bütikofer J; Vogt P; Knoblauch M
Schweiz Med Wochenschr; 1991 Aug; 121(33):1169-75. PubMed ID: 1925445
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension.
Palazzini M; Manes A
Eur Respir Rev; 2009 Sep; 18(113):177-80. PubMed ID: 20956140
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension.
Gürakan B; Kayiran P; Oztürk N; Kayiran SM; Dindar A
Pediatr Pulmonol; 2011 Jun; 46(6):617-20. PubMed ID: 21438177
[TBL] [Abstract][Full Text] [Related]
34. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease.
Palmer SM; Robinson LJ; Wang A; Gossage JR; Bashore T; Tapson VF
Chest; 1998 Jan; 113(1):237-40. PubMed ID: 9440597
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary veno-occlusive disease: an uncommon cause of pulmonary hypertension.
Masters K; Bennett S
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23378546
[TBL] [Abstract][Full Text] [Related]
36. Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis.
Koschel DS; Kolditz M; Höeffken G; Halank M
Med Sci Monit; 2010 May; 16(5):CS55-7. PubMed ID: 20424556
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary veno-occlusive disease and its response to vasodilator agents.
Palevsky HI; Pietra GG; Fishman AP
Am Rev Respir Dis; 1990 Aug; 142(2):426-9. PubMed ID: 2382906
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary veno-occlusive disease.
Veeraraghavan S; Koss MN; Sharma OP
Curr Opin Pulm Med; 1999 Sep; 5(5):310-3. PubMed ID: 10461536
[TBL] [Abstract][Full Text] [Related]
39. Ventilation/perfusion lung scan in pulmonary veno-occlusive disease.
Seferian A; Helal B; Jaïs X; Girerd B; Price LC; Günther S; Savale L; Dorfmüller P; Parent F; Sitbon O; Humbert M; Simonneau G; Montani D
Eur Respir J; 2012 Jul; 40(1):75-83. PubMed ID: 22088969
[TBL] [Abstract][Full Text] [Related]
40. From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Frazier AA; Franks TJ; Mohammed TL; Ozbudak IH; Galvin JR
Radiographics; 2007; 27(3):867-82. PubMed ID: 17495297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
